Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)

Clinical trial NCT05499026 · COMPLETED

Trial details

NCT number: NCT05499026
Sponsor: Leadiant Biosciences Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Cerebrotendinous Xanthomatoses

Start date: 2014-12-09
Primary completion: 2015-06-03
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.